HOME > TOP STORIES
TOP STORIES
-
BUSINESS Anatomy of Mutual Reliance - Diovan Papers and Company Part 1: A Blurred Line
June 20, 2013
-
BUSINESS Novartis Pharma to Voluntarily Refrain from Participation in JPMA’s Board of Directors Meeting
June 19, 2013
-
REGULATORY MHLW to Temporarily Withdraw Recommendation of Preventive Cervical Cancer Vaccinations
June 18, 2013
-
REGULATORY Cabinet Approves PM Abe’s Growth Strategy, Regulatory Reform Plan
June 17, 2013
-
BUSINESS ARBs Still Best Sellers in FY2012 Sales Ranking, Januvia Ranks in Top 10 after only 3 Years of Launch
June 14, 2013
-
REGULATORY CSIMC’s Expert Subcommittee on NHI Drug Pricing Affairs to Hold Hearings for Drug Pricing Organization at Next Meeting in July
June 14, 2013
-
REGULATORY CSIMC Expert Subcommittee: Reps Agree on Need to Redress Price Variations of Generics
June 13, 2013
-
BUSINESS 6 Antipsychotics in PIII Studies; Flurry of NDA Filings Expected in 2015
June 12, 2013
-
REGULATORY Expert Subcommittee to Begin Discussions on Next Year’s NHI Price Revision on June 12
June 11, 2013
-
ORGANIZATION 30% of Newly Listed Drugs in FY2012 Developed at Request of Govt: FPMAJ Survey
June 10, 2013
-
REGULATORY Japan Set to Perk Up R&D to Expand Drug Market to 9 Trillion Yen in 2020
June 7, 2013
-
BUSINESS Nichi-Iko Announces Launching of Authorized Generic of Allegra in June; Is Late Launch Part of Sanofi’s Carefully Worked-out Strategy?
June 7, 2013
-
ACADEMIA Clinical Pharmacology Network to Go Into Operation with 8 Institutions
June 6, 2013
-
REGULATORY Abe Vows to Lift Ban on Online OTC Drug Sales; MHLW to Form Panel to Verify Safety
June 6, 2013
-
BUSINESS Nippon Chemiphar to Outsource Production to Vietnam Next Spring
June 5, 2013
-
ORGANIZATION Sawai Gains Steady Market Shares of Generics in Broad Categories, Meiji Seika Pharma Strong in CNS: Survey
June 4, 2013
-
REGULATORY Study Group Fails to Reach Agreement on Online Sales of OTC Drugs; Final Report to Collate Different Views
June 4, 2013
-
REGULATORY MHLW to Look into Correlations of Pediatric Drug Intakes and Adverse Reactions
June 3, 2013
-
REGULATORY 14 APIs/26 Products Including Third Domestic Biosimilar Receive Listing
June 3, 2013
-
BUSINESS Four Pharmas Launch Filgrastim, Third Biosimilars in Japan
June 3, 2013
ページ
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
